Forecasting Revenue for Drug Pipelines

This problem practices a core healthcare modeling skill, adjusting forecasts for development risk. For pipeline products, candidates need to think through why projected revenue cannot be treated as fully certain, since development, regulatory, manufacturing, and quality control hurdles can prevent a product from ever reaching the market. By contrast, recently launched generics have already cleared key approval and launch milestones, so the forecast logic is different. Interviewers ask this type of question to see whether you understand how uncertainty, approval status, and product complexity affect revenue assumptions in pharmaceutical models.